2. Early medical experts found it extremely difficult to
understand the true function of the organ and they
actually considered pancreas to be nothing more
than a shock absorber.
3. Anatomy overview:
Pancreas is a retroperitoneal organ, lying on posterior
abdominal wall in the C-shaped curvature of duodenum.
Lies at the level of L1 and L2.
Posterior to stomach separated from it by lesser sac.
Divided into 4 parts: head, neck, body and tail.
Around 80g
4.
5. Blood supply:
Splenic artery
Inferior pancreatic artery
Superior pancreaticoduodenal
artery
Inferior pancreaticoduodenal
artery
Pancreatica magna artery
Caudal pancreatic artery
6. Venous Drainage:
Splenic vein
SMV
Portal vein
Lymphatic Drainage:
Celiac nodes
Superior mesenteric nodes
Pancreaticosplenic nodes
Nerve Supply:
Parasympathetic by vagus
Sympathetic by splanchnic plexus
7. Ductal System:
Main pancreatic duct
(duct of Wirsung)
it joins CBD and empties into major
duodenal papilla (ampulla of Vater) in
2nd part of duodenum guarded by
sphincter of Oddi
Accessory pancreatic duct
(duct of Santorini)
It opens into minor duodenal papilla
superior to opening of main pancreatic
duct
8. Pancreas is both exocrine and
endocrine gland
Exocrine portion consists of acinar
cells and ductular cells, secretes
digestive juices i.e. trypsinogen,
lipase, amylase nuclease, elastase,
bicarbonate etc.
Endocrine portion consists of islets of
Langerhans concentrated most in tail,
secretes insulin, glucagon,
somatostatin and PP
9. Acute Pancreatitis
Acute inflammation of pancreas
Premature activation of pancreatic enzymes leading
to autodigestion
Can occur at any age but peak incidence is in young
man and older females
10. Types:
Mild AP
Interstitial inflammation and edema without persistent organ
failure or local complications
Mortality rate of 1%
Severe AP
Pancreatic necrosis accompanied by SIRS, multiple-organ
failure and local complications
Mortality rate of 20-50%
Mortality within 1st week due to multiple-organ failure
Mortality after 1st week is due to septic complication
11. Etiology
GET SMASHED
Gall stone (MCC in Pakistan)
Ethanol (MCC in western world)
Trauma
Steroids
Mumps (coxsakie B and CMV)
Autoimmune
Scorpion venom
Hyperlipidaemia
Hypercalcemia
Heredity
ERCP induced
Drugs (thiazide, furosemide,
estrogen, azathioprine,
sulphonamide etc. )
12. Diagnosis
It requires two of the following three features:
1. Clinical evidence
2. Biochemical Evidence
3. Radiologic Evidence
13. Clinical Presentation
Abdominal pain
Site: Epigastric
Onset: Sudden
Character: Stabbing
Radiation: Back
Associated symptom: Nausea and Vomiting
Timing: Constant
Exacerbating/relieving factor: Movement/Leaning
Severity: Very severe
15. Abdominal Examination
Inspection
Grey-Turner’s sign
Cullen’s sign
Pandiaraja’s sign (ecchymosis of right axilla)
Mild distension
Palpation
Guarding and Tenderness
Auscultation
Absent gut sounds
16. One may find pleural effusion in basal part of chest
on percussion
17. Biochemical Test
Serum amylase
3-5 times above normal limit (<100 U/L)
peaks in 1-2 hrs, returns to normal in 3-5 days
persistent elevation for greater than 10 days
suggests local complication i.e. pseudocyst and
abscess
Serum lipase
3-5 times above upper normal limit (0-50 IU/L)
more sensitive and specific than amylase
also helpful in delayed presentation
18. Radiology
Abdominal X-ray
Sentinel-loop sign
colon cut-off sign
U/S
Does not establish the diagnosis of AP but it must
be done within 24hrs to rule out biliary tract
pathology
21. CT scan
Best single imaging investigation
not done in all pts, its indications are:
If the diagnosis is uncertain
Progressive clinical deterioration
Signs of sepsis
Signs of any organ failure
Any local complication
22. typical findings
focal or diffuse parenchymal enlargement
changes in density because of edema
indistinct pancreatic margins owing to
inflammation
surrounding retroperitoneal fat stranding
liquefactive necrosis of pancreatic parenchyma
lack of parenchymal enhancement
often multifocal
23. infected necrosis
difficult to distinguish from aseptic liquefactive
necrosis
presence of gas is helpful
FNA helpful
abscess formation
circumscribed fluid collection
little or no necrotic tissues (thus distinguishing
it from infected necrosis)
hemorrhage
high-attenuation fluid in the retroperitoneum
or peripancreatic tissues
Renal-halo sign
25. Prognosis
Ranson’s criteria
It is the most frequently utilized predictor of
mortality
Its limitation is that it can not predict severity on
admission (requires 48h)
Ranson’s score 3 or greater suggests severe
Pancreatitis
26.
27. Balthazar CT severity index
It is a prognostic scale based on CT findings
Renal function should be normal
CTSI score: 0-3 ; Mortality 3%, Morbidity 8%
CTSI score: 4-6 ; Mortality 6%, Morbidity 35%
CTSI score: 7-10 ; Mortality 17%, Morbidity 92%
28.
29. Manegement
Mild Pancreatitis
NPO
Aggressive IV fluid resuscitation
Foley’s catheterization and urine output monitoring
Analgesics
Antiemetics
Antibiotics are not indicated
Cholecystectomy in case of gall stone pancreatitis
CT scan only when condition is deterioration
30. Severe Pancreatitis
Admission to HDU
NPO
Aggressive IV fluid resuscitation
Foley’s catheterization and urine output monitoring
Analgesics
Antiemetics
31. Supplementation SaO2 >95%
Monitoring of vital signs, CVP, urine output and blood gases
LFTs, RFTs, serum Ca++, blood glucose, coagulation profile
CT scan
ERCP within 72h of severe gall stone pancreatitis or sings of cholangitis
Supportive therapy for organ failure
Antibiotics: Metronidazole + Imipenem not for >14 days
Nutritional support
Elective cholecystectomy in case of gall stone pancreatitis
32. It can have severe complications and
high mortality despite treatment.
It is believed that “Alexander the
great” died of pancreatitis
35. Pancreatic Pseudocyst
Collection of Pancreatic enzymes rich fluid walled off by
granulation tissue
Psudo because not lined by epithelium
Most common cystic lesion (75%)
Requires 4 or more weeks to develop
Presents with persistent abdominal pain and persistent
elevated amylase level
A mass may be palpated on abdominal exam
36. Diagnosed by US and CT
Differentiated from cystic neoplasm by aspiration
CEA level is high in Cystic Neoplasm
Amylase level is high in pseudocyst but not diagnostic
Cytology reveals inflammatory cells in pseudocyst
Management:
Indications
Symptomatic
Complication
>6 cm and thick walled
Lasting for >12 weeks
To differentiate from tumor
37. Lasting for >12 weeks
To differentiate from tumor
Percutaneous Transgastric cystgastrostomy
Endoscopic transgastric cystgastrostomy
Surgical approach
Cystogastrostomy
Cystodudenostomy
Roux-en-Y Cystojejunostomy
Resection of tail of pancreas